default author photo

Hangxiang Wang

Zhejiang University - NHC Key Laboratory of Combined Multi-Organ Transplantation

Hangzhou, Zhejiang 310003

China

SCHOLARLY PAPERS

1

DOWNLOADS

93

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Identification of a Novel Oral Small-Molecule JAK1/2 Inhibitor and Its Potent Synergistic Drug Combinations Against Cervical Cancer

Number of pages: 30 Posted: 21 Dec 2019
Zhejiang University - State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Zhejiang University, Zhejiang University - State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Zhejiang University - State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Zhejiang University - State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Zhejiang University - State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Zhejiang University - State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Zhejiang University - State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Zhejiang University - NHC Key Laboratory of Combined Multi-Organ Transplantation, Zhejiang University - State Key Laboratory for Diagnosis and Treatment of Infectious Diseases and Zhejiang University
Downloads 93 (730,864)

Abstract:

Loading...

JAK inhibitor; DNMT1 inhibitor; Drug combination; Cell cycle; Apoptosis; Cervical cancer